NCT07187778
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Carcinoma
Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.
8,764 public trials
2,078 recruiting studies
Carcinoma trial results
NCT06479811
- Conditions
- Carcinoma, Cranial Nerve Diseases, Esthesioneuroblastoma, +43 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT06163534
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
- Locations
-
- City of Hope Duarte, California, United States
- USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
- University of California, Los Angeles Los Angeles, California, United States
- Stanford Palo Alto, California, United States
NCT07383441
- Conditions
- Adenocarcinoma, Advanced Clear Cell Renal Cell Carcinoma, Carcinoma, +18 more
- Locations
-
- Highlands Oncology Group - Fayetteville Fayetteville, Arkansas, United States
- NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
- Highlands Oncology Group - Rogers Rogers, Arkansas, United States
- Highlands Oncology Group Springdale, Arkansas, United States
NCT05076760
- Conditions
- Adenocarcinoma, Advanced Cancer, Breast Diseases, +50 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
- Duke Cancer Institute Durham, North Carolina, United States
Recruiting
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
NCT06789172
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +49 more
- Locations
-
- Precision NextGen Oncology and Research Center Beverly Hills, California, United States
- Sarcoma Oncology Center Santa Monica, California, United States
- MD Anderson Cancer Center Houston, Texas, United States
- Chris O'Brien Lifehouse Sydney, New South Wales, Australia
NCT07144319
- Conditions
- Bladder Cancer, Carcinoma, Female Urogenital Diseases, +14 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
- Regents of the University of Michigan Ann Arbor, Michigan, United States
- Rutgers Cancer Institute New Brunswick, New Jersey, United States
- Oslo University Hospital Oslo, Norway
Recruiting
Real-Time MRI-Guided 3-Fraction Accelerated Partial Breast Irradiation in Early Breast Cancer
NCT03936478
- Conditions
- Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +14 more
- Locations
-
- University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States
Recruiting
A Novel Fluorescent Ductal Needle for Localization and Sampling of Micro Lesions in Breast Ducts
NCT07339306
- Conditions
- Adenocarcinoma, Breast Carcinoma In Situ, Breast Diseases, +20 more
- Locations
-
- The Fourth Affiliated Hospital of China Medical University Shenyang, Liaoning, China
Recruiting
DURvalumab in Combination With S-488210/S-488211 vAccine in Non-muscle Invasive Bladder CancEr
NCT04106115
- Conditions
- Bladder Cancer, Carcinoma, Female Urogenital Diseases, +13 more
- Locations
-
- Cambridge University NHS FT Cambridge, United Kingdom
- Guy's and St Thomas' NHS Foundation Trust London, United Kingdom
- Royal Free London NHS FT London, United Kingdom
- The Royal Marsden NHS Foundation Trust London, United Kingdom